Targeting a site of vulnerability on circumsporozoite protein inhibits Plasmodium vivax malaria infection

Study limitation reported by the research below: “The monoclonal antibodies characterized (including GRAM-4) are murine in origin; human antibody responses to PvCSP-B/NAGG remain uncharacterized.”